Clinical trial NCT05186428: Evaluation of a Non-invasive Urinary Collection Technique for the Adaptation of Diuretic Treatment in Incontinent Heart Failure Patient Over 75 Years of Age in the Acute Phase
Official title: Evaluation of a Non-invasive Urinary Collection Technique for the Adaptation of Diuretic Treatment in Incontinent Heart Failure Patient Over 75 Years of Age in the Acute Phase
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Diuresis in Incontinent Patients
Lead sponsor: Poitiers University Hospital
Sponsor class: OTHER
First posted: 2022-01-11
Enrollment: 80
Sex: ALL
Minimum age (years): 75
Maximum age (years): 100
Standard ages: OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: Heart failure is a general disease affecting many organs and regulatory systems with a prevalence of 10% after 75 years of age, leading to significant hospitalization in the elderly. This generates a significant cost for our health system. The management of patients over 75 years of age in acute heart failure requires special monitoring of diuresis and weight. However, it is sometimes difficult to collect urine from incontinent elderly patients (not catheterized, habitually wearing protection) under intravenous diuretics. The evaluation of a non-invasive technique of urine collection for the adaptation of diuretic treatment in the incontinent patient with heart failure over 75 years of age in the acute phase seems to us to be interesting to conduct.


Eligibility criteria: Inclusion Criteria:

* Patient over 75 years of age
* Geriatric short-stay inpatient, geriatric/cardio medicine unit geriatrics
* Incontinent patient with urinary protection
* Patient with acute heart failure according to the diagnosis made by the doctors of unity
* Patient treated with intravenous diuretic
* Patient benefiting from a social security scheme or benefiting from it by a third party
* Patient who gave their non-opposition to the study after clear information

Exclusion Criteria:

* Patient hospitalized in another unit of the geriatric division
* Patient allergic to the protections provided
* Patient carrying a bladder probe upon entry into the unit
* Patient with a precarious non-perfusable venous capital

Primary outcomes:
measure: Comparison of the duration of intravenous diuretic treatment during 2 periods
timeFrame: 15 days maximum
Secondary outcomes:
measure: Comparison comfort of patient between the 2 periods with VAS
timeFrame: 15 days maximum
measure: Compare between the 2 periods the rate of skin complications related to the 2 diuresis assessment techniques,
timeFrame: 15 days maximum
measure: Compare between the 2 periods the rate of bladder catheterization during the study
timeFrame: 15 days maximum
measure: Compare the mortality rate between the 2 periods
timeFrame: 15 days maximum
measure: Compare the average length of stay of patients between the 2 periods
timeFrame: 15 days maximum
Other outcomes:
Locations:
city: Poitiers
country: France
facility: CHU de Poitiers
Study officials:
affiliation: CHU de Poitiers FRANCE
name: Sophie PAJOUX
role: PRINCIPAL_INVESTIGATOR
References: